SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, today announced that it is to invest in its Mumbai, India, facility, in a move which will see the current 1,393 sq m laboratory more than double in size, to 3,994 sq m. The expansion is being driven by increasing demand for Full Time Equivalent (FTE) activities for key pharmaceutical customers, as well as more stability projects from both local operations of Multi-National Companies and overseas organisations.

The expanded laboratory will act as a dedicated cGMP pharmaceutical testing site and is due for completion and validation in Q2 2015.

The Mumbai facility, which is focused on stability studies and dedicated FTE models, will feature three new 100 cubic meter capacity stability chambers, HPLCs, dissolutions, gas chromatographs and additional general laboratory instruments. Capacity at the site will grow from 423 cubic meters to 723 cubic meters, while the current 88 strong workforce will ultimately be augmented by an additional 39 members of staff.

“The expansion will bring additional facilities, expertise and personnel to serve our customers’ requirements in Asia,” commented Paul House, Managing Director of SGS India Ltd. “Upon completion, the Mumbai laboratory will be the largest stability testing facility in our Life Science Services network.”

With 21 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonised solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I to IV clinical trial management and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.


SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 80,000 employees, SGS operates a network of over 1,650 offices and laboratories around the world.

For further information, please contact:

Ferdinand Dabu
Global Marketing Director
Life Science Services
75 Passaic Avenue,
Fairfield, NJ 07004, USA
t: +1-973-287-1219

Richard Kerns
6 Penny Black Chambers,
Manchester M28 2PD, UK
t: +44 (0) 161 728 5880